ClinConnect ClinConnect Logo
Search / Trial NCT05369299

Clinical Outcome of Two-piece Zirconia Implants in Immediate Implant Placement

Launched by MEDICAL UNIVERSITY OF GRAZ · May 10, 2022

Trial Information

Current as of May 14, 2025

Active, not recruiting

Keywords

Zirconium Oxide Dental Implants Prospective Studies Osseointegration Resonance Frequency Analysis Patient Reported Outcome Measures Esthetics

ClinConnect Summary

This clinical trial is studying a new type of dental implant made from zirconia, which is a white ceramic material. The goal is to find out if these two-piece zirconia implants are as effective as traditional titanium implants for patients who need immediate dental implants—meaning the implant is placed right after a tooth is removed. They are currently looking for participants aged 18 and older who are in good health, have good oral hygiene, and have gaps where teeth are missing in their upper or lower jaws.

To take part in the trial, participants should not smoke and should not have certain health issues that could complicate the implant procedure, like active gum disease or uncontrolled diabetes. Those who join the study can expect to receive an implant and will be monitored to see how well it works compared to the standard titanium option. This research is important because it could help determine if zirconia implants are a viable choice for patients needing immediate tooth replacements.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients giving informed consent to participate in the clinical trial and fulfil the following criteria will be included in the investigation:
  • 1. good oral hygiene standard;
  • 2. good general health;
  • 3. 18 years or older;
  • 4. non-smokers;
  • 5. presence of single-tooth or multiple gaps in the mandible or the maxilla;
  • 6. intact facial bone wall;
  • 7. sufficient bone volume to support an implant of at least 10 mm length.
  • 8. Teeth with removable periapical lesions are included.
  • Exclusion Criteria:
  • Primary exclusion criteria are as follows:
  • 1. parafunctional habits;
  • 2. active periodontitis;
  • 3. smoking;
  • 4. pregnancy;
  • 5. acute or chronic medical conditions for which implant therapy has always been considered a contraindication: uncontrolled diabetes (HbA1c \>8.0%), mucosal disease, untreated periodontitis, immunological disorders, active malignancy, alcoholism, condition after radiation therapy to the head and neck area and antiresorptive therapy.
  • Secondary exclusion criteria will be applied at surgical procedure:
  • 6. loss of facial bone wall due to extraction procedure;
  • 7. insufficient primary stability (less than 32Ncm insertion torque).

About Medical University Of Graz

The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.

Locations

Graz, Styria, Austria

Patients applied

0 patients applied

Trial Officials

Raoul Polansky, DMD

Principal Investigator

Department of Dentistry and Oral Health, Medical University of Graz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials